Unichem Laboratories [UNICHEMLAB] vs Indraprastha Medical [INDRAMEDCO] Detailed Stock Comparison
Unichem Laboratories
NSE
Loading...
Indraprastha Medical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Unichem Laboratories wins in 8 metrics, Indraprastha Medical wins in 10 metrics, with 0 ties. Indraprastha Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Unichem Laboratories | Indraprastha Medical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 28.25 | 26.75 | Indraprastha Medical |
| Price-to-Book Ratio | 1.44 | 7.52 | Unichem Laboratories |
| Debt-to-Equity Ratio | 18.76 | 5.49 | Indraprastha Medical |
| PEG Ratio | -0.13 | 1.79 | Unichem Laboratories |
| EV/EBITDA | 16.19 | 16.33 | Unichem Laboratories |
| Profit Margin (TTM) | 5.80% | 12.21% | Indraprastha Medical |
| Operating Margin (TTM) | -1.77% | 17.25% | Indraprastha Medical |
| EBITDA Margin (TTM) | N/A | 17.25% | N/A |
| Return on Equity | 5.61% | 26.98% | Indraprastha Medical |
| Return on Assets (TTM) | 3.85% | 18.90% | Indraprastha Medical |
| Free Cash Flow (TTM) | $-1.44B | $1.20B | Indraprastha Medical |
| Dividend Yield | N/A | 1.13% | N/A |
| 1-Year Return | -22.76% | -0.48% | Indraprastha Medical |
| Price-to-Sales Ratio (TTM) | 1.64 | 3.26 | Unichem Laboratories |
| Enterprise Value | $38.90B | $41.34B | Indraprastha Medical |
| EV/Revenue Ratio | 1.81 | 3.01 | Unichem Laboratories |
| Gross Profit Margin (TTM) | 53.47% | 38.19% | Unichem Laboratories |
| Revenue per Share (TTM) | $307 | $150 | Unichem Laboratories |
| Earnings per Share (Diluted) | $17.70 | $18.27 | Indraprastha Medical |
| Beta (Stock Volatility) | -0.17 | 0.61 | Unichem Laboratories |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Unichem Laboratories vs Indraprastha Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Unichem Laboratories | 1.22% | 0.36% | 1.64% | -14.34% | -25.03% | -31.18% |
| Indraprastha Medical | -1.13% | 6.58% | 5.85% | 12.75% | 45.91% | -12.01% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Unichem Laboratories | -22.76% | 32.31% | 95.48% | 88.25% | 163.92% | 455.54% |
| Indraprastha Medical | -0.48% | 598.46% | 848.66% | 697.82% | 960.51% | 877.85% |
News Based Sentiment: Unichem Laboratories vs Indraprastha Medical
Unichem Laboratories
News based Sentiment: MIXED
September presented a mixed bag for Unichem Laboratories, with a positive USFDA report countered by a net loss in Q1 FY26 and fluctuating stock performance. While long-term forecasts are optimistic, short-term challenges require careful consideration, making this a moderately significant month for investors.
Indraprastha Medical
News based Sentiment: MIXED
Indraprastha Medical delivered improved profitability in Q1 FY2026, but slower revenue growth and an unclear price target from HDFC Securities create a mixed investment picture. The announcement of a strategic shift and new product line adds an element of potential, but requires further investigation.
Performance & Financial Health Analysis: Unichem Laboratories vs Indraprastha Medical
| Metric | UNICHEMLAB | INDRAMEDCO |
|---|---|---|
| Market Information | ||
| Market Cap | ₹35.23B | ₹44.25B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 31,505 | 159,391 |
| 90 Day Avg. Volume | 43,655 | 194,344 |
| Last Close | ₹506.10 | ₹476.70 |
| 52 Week Range | ₹483.00 - ₹937.95 | ₹307.25 - ₹572.00 |
| % from 52W High | -46.04% | -16.66% |
| All-Time High | ₹937.95 (Nov 04, 2024) | ₹572.00 (Jan 06, 2025) |
| % from All-Time High | -46.04% | -16.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.18% | 0.05% |
| Quarterly Earnings Growth | 0.18% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.12% |
| Operating Margin (TTM) | -0.02% | 0.17% |
| Return on Equity (TTM) | 0.06% | 0.27% |
| Debt to Equity (MRQ) | 18.76 | 5.49 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹348.07 | ₹65.04 |
| Cash per Share (MRQ) | ₹12.72 | ₹35.08 |
| Operating Cash Flow (TTM) | ₹-1,166,300,000 | ₹1.78B |
| Levered Free Cash Flow (TTM) | ₹1.38B | ₹1.61B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.13% |
| Last 12-Month Dividend | ₹0.00 | ₹4.50 |
Valuation & Enterprise Metrics Analysis: Unichem Laboratories vs Indraprastha Medical
| Metric | UNICHEMLAB | INDRAMEDCO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 28.25 | 26.75 |
| Forward P/E | N/A | 195.50 |
| PEG Ratio | -0.13 | 1.79 |
| Price to Sales (TTM) | 1.64 | 3.26 |
| Price to Book (MRQ) | 1.44 | 7.52 |
| Market Capitalization | ||
| Market Capitalization | ₹35.23B | ₹44.25B |
| Enterprise Value | ₹38.90B | ₹41.34B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.81 | 3.01 |
| Enterprise to EBITDA | 16.19 | 16.33 |
| Risk & Other Metrics | ||
| Beta | -0.17 | 0.61 |
| Book Value per Share (MRQ) | ₹348.07 | ₹65.04 |
Financial Statements Comparison: Unichem Laboratories vs Indraprastha Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | UNICHEMLAB | INDRAMEDCO |
|---|---|---|
| Revenue/Sales | ₹5.27B | ₹3.34B |
| Cost of Goods Sold | ₹2.45B | ₹2.13B |
| Gross Profit | ₹2.82B | ₹1.21B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-93.00M | ₹504.10M |
| EBITDA | ₹293.10M | ₹676.70M |
| Pre-Tax Income | ₹-90.20M | ₹552.70M |
| Income Tax | ₹14.50M | ₹142.60M |
| Net Income (Profit) | ₹-104.70M | ₹410.10M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | UNICHEMLAB | INDRAMEDCO |
|---|---|---|
| Cash & Equivalents | ₹895.80M | ₹614.80M |
| Total Current Assets | ₹20.29B | ₹4.31B |
| Total Current Liabilities | ₹9.92B | ₹1.79B |
| Long-Term Debt | ₹860.00M | ₹305.40M |
| Total Shareholders Equity | ₹24.51B | ₹5.97B |
| Retained Earnings | ₹24.56B | N/A |
| Property, Plant & Equipment | ₹12.79B | ₹3.27B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | UNICHEMLAB | INDRAMEDCO |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | ₹-5.07B | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | UNICHEMLAB | INDRAMEDCO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 31,505 | 159,391 |
| Average Daily Volume (90 Day) | 43,655 | 194,344 |
| Shares Outstanding | 70.41M | 91.67M |
| Float Shares | 20.17M | 41.01M |
| % Held by Insiders | 0.71% | 0.58% |
| % Held by Institutions | 0.10% | 0.03% |
Dividend Analysis & Yield Comparison: Unichem Laboratories vs Indraprastha Medical
| Metric | UNICHEMLAB | INDRAMEDCO |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹4.50 |
| Last 12-Month Dividend Yield | N/A | 1.13% |
| 3-Year Avg Annual Dividend | ₹1.33 | ₹3.33 |
| 3-Year Avg Dividend Yield | 1.34% | 2.17% |
| 3-Year Total Dividends | ₹4.00 | ₹10.00 |
| Ex-Dividend Date | Aug 01, 2022 | Sep 13, 2024 |